Quest Diagnostics Incorporated (DGX)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 1,175,000 | 1,113,000 | 1,116,000 | 1,119,000 | 1,130,000 | 1,005,000 | 1,057,000 | 1,063,000 | 1,238,000 | 1,628,000 | 1,931,000 | 2,425,000 | 2,599,000 | 2,855,000 | 2,954,000 | 2,392,000 | 1,884,000 | 1,454,000 | 971,000 | 981,000 |
| Revenue (ttm) | US$ in thousands | 9,872,000 | 9,539,000 | 9,346,000 | 9,287,000 | 9,252,000 | 9,297,000 | 9,488,000 | 9,603,000 | 9,883,000 | 10,294,000 | 10,582,000 | 10,679,000 | 10,788,000 | 11,046,000 | 11,058,000 | 10,335,000 | 9,437,000 | 8,361,000 | 7,531,000 | 7,657,000 |
| Pretax margin | 11.90% | 11.67% | 11.94% | 12.05% | 12.21% | 10.81% | 11.14% | 11.07% | 12.53% | 15.82% | 18.25% | 22.71% | 24.09% | 25.85% | 26.71% | 23.14% | 19.96% | 17.39% | 12.89% | 12.81% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $1,175,000K ÷ $9,872,000K
= 11.90%
Quest Diagnostics Incorporated's pretax margin shows fluctuations over the period from March 31, 2020, to December 31, 2024. The company's pretax margin started at 12.81% in March 2020, gradually increasing to 26.71% in June 2021, indicating improved profitability. However, the pretax margin began to decline after reaching its peak in June 2021, dropping to 11.90% by December 31, 2024.
The trend suggests that Quest Diagnostics experienced a period of strong profitability from 2020 to mid-2021, followed by a period of decreasing profitability. This may indicate changes in the company's cost structure, revenue streams, or operational efficiency during the latter half of the analysis period.
Overall, monitoring the pretax margin can provide insights into Quest Diagnostics' earnings performance and efficiency in generating profits before accounting for taxes and can be valuable for assessing the company's financial health and management effectiveness.
Peer comparison
Dec 31, 2024